A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy.
Clinical trial NCT05155709 · COMPLETED
Trial details
- NCT number
- NCT05155709
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-17
- Primary completion
- 2024-04-17
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.